© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
867183 |
As an accredited 8-Bromo-Imidazo[1,2-A]Pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 8-Bromo-Imidazo[1,2-A]Pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every once in a while, a compound comes along that lends a precise edge to research labs and production floors. 8-Bromo-Imidazo[1,2-A]Pyridine brings that kind of distinct identity to the world of heterocyclic chemistry. At first glance, its name hints at a specific modification: a bromine atom attached to the imidazo[1,2-a]pyridine core. This tweak may look minor, but its impact runs deep throughout chemical, pharmaceutical, and material science communities.
Any chemist who has spent years poring over reaction schemes knows the challenge of finding reliable starting points. Over time, certain molecules stick out because they actually get real results. This compound, featuring the sturdy imidazopyridine framework with a bromine atom at the 8-position, often serves as a stepping stone for crafting tailored drug candidates and functional materials. Its unique fusion of pyridine and imidazole rings gives synthetic chemists flexibility when building complex structures, especially in medicinal research pushing the boundaries of what’s possible.
Placing a bromine at position 8 on the imidazo[1,2-a]pyridine skeleton means reactivity shifts just enough to unlock unusual substitution patterns. Many years ago, I tried synthesizing kinase inhibitors with an unsubstituted imidazopyridine core. Decent results, but selectivity suffered. With a brominated analog, suddenly more controlled functionalization was on the table. That kind of practical difference carries real consequences for project timelines and resource allocation—chemists working with persistent targets know the value of shaving off a week from optimization cycles.
In this industry, too many product pages hide behind jargon or offer endless tables of properties that don’t mean much on the bench. With 8-Bromo-Imidazo[1,2-A]Pyridine, what matters comes down to a few critical characteristics: purity, form, and reliability of supply.
The compound usually arrives as a pale to off-white crystalline powder, stored in light-resistant bottles or ampoules. Most reputable vendors guarantee high purity levels—often 98% or better—since even small traces of byproducts can derail sensitive coupling reactions. Molecular weight sits at 223.07 g/mol, with a melting point in the expected range for such fused aromatics. Everyone who’s ever fretted about NMR spectroscopy or LC-MS data will recognize the relief of seeing clean, sharp peaks and absent scattering. In routine use, the substance dissolves in common solvents like DMSO and DMF and holds up well under inert handling conditions.
It’s one thing to have a functionalized heterocycle on the shelf; it’s another to use one that gives options. Bromine atoms act as practical handles in modern organic synthesis. My own experience bears this out. More than once, a bromo-derivative saved me hours at the lab bench, since Suzuki and Buchwald-Hartwig cross-coupling reactions run cleaner and with greater scope than their chloro- or iodo-cousins. Not only do bromides offer a sweet spot in terms of reactivity—fast enough to couple, but not so fast you lose control—their predictable chemistry makes them favorite entry points for creating libraries of analogs.
Most teams working on small molecule discovery know that time spent troubleshooting obscure halides rarely pays dividends. Bringing in a product such as 8-Bromo-Imidazo[1,2-A]Pyridine pulls together years of reaction optimization into a readily accessible building block. Medicinal chemists can tack on new functional groups, while materials scientists introduce electron-withdrawing or electron-donating motifs where they matter most. That kind of interoperability fosters project efficiency.
Chemical purity gets a lot of lip service. In the real world, even a trace impurity in a reagent can spell disaster. As a graduate student, I learned the hard way that a single percent of an unknown in a starting material can put a whole synthetic sequence off-kilter. With 8-Bromo-Imidazo[1,2-A]Pyridine, reliable suppliers provide not just a certificate of analysis, but deliver material that performs batch after batch, year after year. Purity, cleanliness of NMR and HPLC spectra, absence of moisture, and solidity in air—these become non-negotiable traits for any serious bench scientist.
Many demand numbers: how many milligrams, what melting point, which spectra confirm identity. Real trust, though, comes from repeated results. This compound’s formulation and packaging focus on keeping that trust. Typical aliquots come desiccated, minimizing risk of degradation or unwanted side reactions. Laboratories with stringent inventory requirements find this approach appealing, since nobody wants firefighting during a tight deadline because a reagent failed simple handling.
Some reagents feel like one-trick ponies—stuck serving just a single purpose. 8-Bromo-Imidazo[1,2-A]Pyridine, on the other hand, proves versatile. Researchers turn to it for constructing more complex imidazopyridine derivatives destined for medicinal chemistry screens. This scaffold shows up in kinase inhibitors, anti-infectives, and molecular probes designed for diagnostic imaging. The presence of the bromine atom enables straightforward diversification, allowing swift, iterative analog development during lead optimization. Such efficiency can make the difference in progressing a compound from idea to animal testing in record time.
One example close to my own work: finding selectivity for central nervous system targets typically comes down to subtle changes in molecular structure. Swapping in 8-Bromo-Imidazo[1,2-A]Pyridine and then customizing at the 8-position through cross-coupling often unveiled new SAR (structure-activity relationship) insights. Those moments—when one reagent opens up a new direction—are behind much of the progress in exploratory research.
Within the family of imidazo[1,2-a]pyridines, each variant tells a story of reactivity and intended use. Unsubstituted versions, or those halogenated elsewhere on the ring, behave differently under the same reaction conditions. Chlorinated analogs, for example, suffer from sluggish couplings and sometimes unwanted rearrangements. I remember testing iodo variants; reactivity soared but product purification became a headache thanks to side-reactions and higher rates of decomposition. Bromine at the 8-position finds an ideal middle: efficient and controllable, but with lower risk of runaway reactions. This translates to fewer wasted reagents, less time running columns, more reliable yields.
Much of the research community values flexibility—the ability to attach a variety of new groups, explore uncharted biological space, and switch smoothly from gram-scale synthesis to multi-gram runs. 8-Bromo-Imidazo[1,2-A]Pyridine fits that demand. While related molecules offer similar frameworks, only the brominated version gives that crucial blend of controlled reactivity and ease of functionalization.
Anyone who has spent years in a lab recognizes that new reagents bring new handling concerns. 8-Bromo-Imidazo[1,2-A]Pyridine doesn’t demand much beyond standard organic laboratory protocol. Common sense rules: gloves, good ventilation, waste disposal in line with brominated organics. The compound resists rapid hydrolysis, doesn't emit strong odors, and can be stored for months with no loss in quality if kept dry and cool. Its manageability means advanced projects don't stall due to excessive safety protocols.
One enduring lesson: time invested upfront on basic safety training pays off in longer and less interrupted research runs. Nobody looks forward to dealing with emergency protocols because of a poorly stored or mishandled fine chemical. Precautions made part of the daily routine serve everybody, and this product’s relative robustness helps keep things running smoothly.
Seasoned researchers remember the frustration of interrupted projects caused by out-of-stock materials or inconsistent batches. Building a track record of success means picking vendors that respect precision and reliability. With 8-Bromo-Imidazo[1,2-A]Pyridine, respected suppliers subject every production run to thorough testing: melting point checks, spectroscopic verification, and impurity profiling. This isn’t about ticking boxes; real laboratories need results that match documentation—a lesson reinforced again and again by overnight reactions gone awry.
The predictability of clean reactions marks the difference between high-throughput screens that deliver actionable results and hand-waved error bars that get missed in peer review. By sourcing material with a proven supply chain, teams sidestep the unrecoverable costs of failed syntheses. Long-term collaborations often build on trusted batches booked ahead of schedule, reducing downtime and giving scientists room to focus on fresh ideas, not logistical headaches.
Quality control has grown stricter as regulatory and funding agencies demand data with traceable quality. Lab managers and team leads have pushed for standardization in reagents. For 8-Bromo-Imidazo[1,2-A]Pyridine, uniformity in appearance, solubility, and performance offers fewer surprises in downstream analytic and biological testing. This saves projects from the “unknown unknowns” that crop up with poorly synthesized or hastily purified compounds.
In my own early trials, producing a batch in-house resulted in variable yields and inconsistent TLC profiles. Buying standardized material meant fewer weekends spent troubleshooting basic steps. Where teams juggle compliance audits or need to reproduce results across continents, the predictability of a trusted commercial reagent pays off. Standardized packaging and lot tracking also support audit trails, keeping everyone accountable and more confident in their research pipelines.
While the pharmaceutical industry dominates the use case list for this scaffold, the story doesn’t stop there. Researchers in materials science and chemical biology are finding fresh opportunities with 8-Bromo-Imidazo[1,2-A]Pyridine. Its adaptable core structure draws interest for synthesizing probes used in imaging and signal amplification, along with compounds for optoelectronic experiments.
Building bridges between seemingly unrelated fields often starts with a versatile reagent. For years, cross-disciplinary teams faced clashing protocols and mismatched inventory. A robust chemical with defined behavior across conditions—dissolving evenly, reacting consistently—lowers the barriers for collaboration between medicinal chemistry teams, cell biologists, and engineers. The knock-on effects? More creative research questions, tighter data, and quicker pivots to promising directions.
Now more than ever, the cost of specialty building blocks affects what kinds of research move forward. Tight budgets or procurement delays can slow down ambitious projects in both academia and industry. 8-Bromo-Imidazo[1,2-A]Pyridine, as a specialty compound, isn’t immune to such pressures. Bulk purchasing and long-term supplier agreements offer some relief. In leaner groups, shared procurement networks or regional consortia can help secure necessary quantities at more manageable pricing.
Sustainability, too, is no longer just a buzzword. The presence of bromine flags concerns about waste disposal, environmental persistence, and possible regulatory restrictions. Researchers and product managers face growing mandates to minimize halogenated waste streams. Alternative synthesis pathways, on-site solvent recycling, and pre-packaged aliquot systems all contribute to reducing the environmental footprint. Some laboratories have adopted closed-loop systems for handling and destroying brominated waste, passing both internal safety reviews and external compliance checks with less fanfare. Progress here takes persistent effort and a willingness to rethink habits built up over decades in the hope of longer-term sustainability.
Lab manuals and MSDS sheets provide necessary reference points, but lived experience tells the deeper story. Taking 8-Bromo-Imidazo[1,2-A]Pyridine from vial to reaction flask demands a blend of care and boldness. I’ve seen younger colleagues hesitant to commit expensive bromo-heterocycles to a tricky coupling, only to hit breakthrough yields with a well-tuned protocol. Real progress often comes from learning what works under pressure: how quickly it dissolves, whether a scrap of moisture will make or break an experiment, or just how long to push a reaction before the crude turns unworkable.
The wisdom of repeated trial and error, passed down through hands-on mentoring, shapes how products like this get utilized. Graduate students pick up on best practices distinct from the finer points in a technical data sheet. High-throughput labs, where every reagent must justify its place, often document not just the outcome but the path they took—waiting to see if new starting points, like 8-Bromo-Imidazo[1,2-A]Pyridine, earn a spot in standard operating protocols.
The direction of chemical discovery leans on access to reliable building blocks. For scientists curious about new mechanisms or hoping to test unorthodox ideas, standard reagents open doors. Much of today’s pipeline for novel therapeutics—even strategies for combating drug resistance—builds on carefully modified heterocycles. The bromine-substituted imidazopyridine offers an entryway for rapid analog creation, opening up more chemical space to explore.
What counts isn’t just high purity and consistent supply—vital as those are—but the way such a compound helps research teams move from concept to answer faster than before. Institutions investing in adaptable, well-characterized reagents send a signal: they are prepared to back their people with the tools needed to stay competitive. Close collaboration with technical support teams, direct feedback from users, and quick handling of shipment or storage hiccups round out the picture of modern product delivery.
Scientists and procurement managers often play a guessing game, trying to anticipate which scaffolds or reagents will matter most five years down the line. As research priorities shift, so does demand for specific building blocks. Trends show increasing interest in late-stage functionalization, greener protocols, and diversified small-molecule libraries. Flexible scaffolds like 8-Bromo-Imidazo[1,2-A]Pyridine stay relevant because they adapt to new technological and methodological advances.
Over the last decade, more automated synthesis platforms and parallel screening protocols have emerged. Reagents that play nicely with liquid handling robots and tolerate a bit of rough-and-tumble shipping serve an ever-broader audience. The ease with which brominated imidazopyridines dovetail with high-throughput reaction optimization can give smaller labs an edge, letting them punch above their weight in the race for innovative leads or publishable mechanistic breakthroughs.
No compound exists in a vacuum. Research communities depend on open lines of communication. Synthetic schemes, reaction troubleshooting, purity assays—all find their way into forums, group meetings, and preprint servers. Early-career scientists especially benefit when more experienced hands document and share tips about handling, purification, and downstream couplings of 8-Bromo-Imidazo[1,2-A]Pyridine.
Much of the collective wisdom about a specific scaffold grows organically as labs worldwide report both successes and failures. Keeping feedback flowing between the bench and the suppliers shortens the gap between needs and quality improvements. Vendors committed to growing with their community invest in channels that let these conversations thrive, looping back user innovations and frustrations alike into better products year on year.
The point of bringing a specialized fine chemical into the lab isn’t just to collect more bottles. 8-Bromo-Imidazo[1,2-A]Pyridine fits best where practical, everyday challenges meet innovative thinking. Whether for confirming a new kinase inhibitor, developing an imaging probe, or synthesizing a more effective small-molecule tool, it represents a partnership between supplier quality and bench inspiration.
I’ve come to appreciate not just the technical reasons this scaffold stands out, but also the way its dependability takes some pressure off high-stakes experiments. By trusting defined, quality-controlled materials, researchers open more time for the creative and uncertain parts of science—the place where advances actually happen. Solving problems, not just describing them, starts with having reliable basics on hand. With a strong building block like this in the toolkit, projects gain the extra runway needed to reach the next breakthrough.
